1. Home
  2. TJGC vs DRIO Comparison

TJGC vs DRIO Comparison

Compare TJGC & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TJGC Group Limited Ordinary Shares

TJGC

TJGC Group Limited Ordinary Shares

N/A

Current Price

$3.97

Market Cap

44.1M

ML Signal

N/A

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$7.48

Market Cap

52.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TJGC
DRIO
Founded
2022
2011
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Advertising
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.1M
52.8M
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
TJGC
DRIO
Price
$3.97
$7.48
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
990.5K
27.5K
Earning Date
08-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1559.02
EPS
N/A
1.75
Revenue
N/A
$7,394,000.00
Revenue This Year
N/A
$20.27
Revenue Next Year
N/A
$47.58
P/E Ratio
N/A
$4.33
Revenue Growth
N/A
43.02
52 Week Low
$0.49
$0.43
52 Week High
$7.07
$17.74

Technical Indicators

Market Signals
Indicator
TJGC
DRIO
Relative Strength Index (RSI) 42.78 53.79
Support Level $0.80 $7.18
Resistance Level $5.01 $8.29
Average True Range (ATR) 0.44 0.81
MACD -0.10 0.01
Stochastic Oscillator 34.96 68.53

Price Performance

Historical Comparison
TJGC
DRIO

About TJGC TJGC Group Limited Ordinary Shares

TJGC Group Ltd, formerly CTRL Group Ltd is an integrated marketing and advertising services provider in Hong Kong specializing in mobile games promotion for the local market. It provide services to mobile game developers, principally developers of mobile gaming applications or apps that gamers download from the developers' websites and applicable mobile operating systems, such as Apple Store or Android Google Play Store.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: